The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
The roughly six-hour flyby in 1986 revealed Uranus' protective magnetic field was strangely empty. Now, researchers say that the data could have been affected by a solar wind event November 13 ...